Cases & Deals

  • Home
  • Practices
  • Baxter International defends against multidistrict antitrust class actions involving plasma derived biological products

Share

Baxter International defends against multidistrict antitrust class actions involving plasma derived biological products

April 2014

Client(s) Baxter International Inc.

Jones Day defended Baxter International Inc. in several antitrust class action lawsuits brought by a group of hospitals alleging that Baxter and other producers conspired to limit production and fix prices of certain plasma protein products sold in the United States. After five years of litigation, the parties' settlement agreement was approved by the court on April 16, 2014.

In re Plasma-Derivative Protein Therapies Antitrust Litigation, MDL No. 2109 (N.D. Ill., filed Aug. 2009)

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.